Related Experiment Video

Updated: Jul 19, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:15

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

123

Scoping Review of Measures of Comorbidities in Heart Failure

Jihyang Lee, Oonjee Oh, Da-In Park

    The Journal of Cardiovascular Nursing
    |August 8, 2023
    PubMed

    Insights

    Assessing comorbidities in heart failure patients is crucial for predicting outcomes, but current methods lack standardization. This review highlights inconsistencies in comorbidity measurement, emphasizing the need for clear guidelines to improve clinical outcome prediction.

    Area of Science:

    • Cardiology
    • Clinical Research Methodology

    Background:

    • Comorbidities significantly impact heart failure patient outcomes.
    • Standardized methods for assessing comorbidities in heart failure are lacking.

    Purpose of the Study:

    • To review comorbidity assessment methods in heart failure research.
    • To identify chronic conditions studied as comorbidities.
    • To evaluate the rationale behind selecting comorbidity assessment tools and specific conditions.

    Main Methods:

    • Systematic literature review of 39 articles.
    • Searches across three electronic databases and reference lists.
    • Analysis of comorbidity assessment strategies (instruments, disease counts, individual conditions).

    Main Results:

    • Three assessment approaches were identified: using instruments (e.g., Charlson Comorbidity Index), disease counts, and individual comorbidities.
    • Ninety comorbidities were analyzed, but definitions and labels were inconsistent.
    • Over half of studies (22/39) lacked a clear rationale for instrument or comorbidity selection, with some rationales being inappropriate.

    Conclusions:

    • Significant methodological issues exist in measuring comorbidities for heart failure clinical outcomes.
    • Researchers must address these issues for accurate comorbidity assessment.
    • Development of guidelines for selecting appropriate comorbidity measures is necessary.
    Abstract

    More Related Videos

    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index06:55

    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

    Published on: January 8, 2020

    14.5K
    Development of a Virtual Reality Assessment of Everyday Living Skills10:32

    Development of a Virtual Reality Assessment of Everyday Living Skills

    Published on: April 23, 2014

    18.5K

    Related Concept Videos

    Heart Failure IV: Classification and Diagnostic Evaluation01:30

    Heart Failure IV: Classification and Diagnostic Evaluation

    Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
    19
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    13
    Heart Failure III: Clinical Manifestations01:26

    Heart Failure III: Clinical Manifestations

    Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
    23
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    15
    Heart Failure I: Introduction01:27

    Heart Failure I: Introduction

    Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
    16
    Heart Failure VI: Adjunct Therapies01:22

    Heart Failure VI: Adjunct Therapies

    Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
    16